Log in to save to my catalogue

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4743652

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

About this item

Full title

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2012-02, Vol.11 (2), p.125-140

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
All RNA-targeted therapeutic technologies exploit oligonucleotides that bind to target RNA, but they differ in their mechanism of action and produce different effects.
Small interfering RNAs, antisense oligonucleotides and external guide sequences lead to enzyme-dependent degradation of targeted mRNA. Drugs involving these approach...

Alternative Titles

Full title

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4743652

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4743652

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd3625

How to access this item